Cargando…

The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) constitutes the most common endocrine disorder in women of reproductive age. Patients usually suffer from severe menstrual irregularities, skin conditions, and insulin resistance-associated health conditions. Peroxisome proliferator-activated receptors (PPARs) are nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Psilopatis, Iason, Vrettou, Kleio, Nousiopoulou, Eleni, Palamaris, Kostas, Theocharis, Stamatios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141215/ https://www.ncbi.nlm.nih.gov/pubmed/37109247 http://dx.doi.org/10.3390/jcm12082912

Ejemplares similares

The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)

The Role of Peroxisome Proliferator-Activated Receptors in Preeclampsia
por: Psilopatis, Iason, et al.
Publicado: (2023)

Organoids: A New Chapter in Sarcoma Diagnosis and Treatment
por: Psilopatis, Iason, et al.
Publicado: (2022)

The Role of MicroRNAs in Uterine Leiomyosarcoma Diagnosis and Treatment
por: Psilopatis, Iason, et al.
Publicado: (2023)

The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023)

The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
por: Psilopatis, Iason, et al.
Publicado: (2023)

EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2022)

The Impact of Histone Modifications in Endometriosis Highlights New Therapeutic Opportunities
por: Psilopatis, Iason, et al.
Publicado: (2023)

Thymic Epithelial Neoplasms: Focusing on the Epigenetic Alterations
por: Psilopatis, Iason, et al.
Publicado: (2022)

The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
por: Psilopatis, Iason, et al.
Publicado: (2022)

Ovarian Torsion in Polycystic Ovary Syndrome: A Potential Threat?
por: Psilopatis, Iason, et al.
Publicado: (2023)

Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
por: Psilopatis, Iason, et al.
Publicado: (2022)

May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
por: Psilopatis, Iason, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
por: Psilopatis, Iason, et al.
Publicado: (2021)

Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma
por: Palamaris, Kostas, et al.
Publicado: (2022)

Peroxisome Proliferator-Activated Receptor-γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer
por: Giaginis, Costas, et al.
Publicado: (2008)

Unraveling the Immune Microenvironment of Thymic Epithelial Tumors: Implications for Autoimmunity and Treatment
por: Masaoutis, Christos, et al.
Publicado: (2022)

Expression of the genes for peroxisome proliferator-activated receptor-γ, cyclooxygenase-2, and proinflammatory cytokines in granulosa cells from women with polycystic ovary syndrome
por: Lee, Joong Yeup, et al.
Publicado: (2017)

Role of the Peroxisome Proliferator-Activated Receptors, Adenosine Monophosphate-Activated Kinase, and Adiponectin in the Ovary
por: Dupont, Joëlle, et al.
Publicado: (2008)

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2023)

Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

Estrogen Receptors in Polycystic Ovary Syndrome
por: Xu, Xue-Ling, et al.
Publicado: (2021)

The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome
por: Kem, David C, et al.
Publicado: (2020)

Initiation of the expression of peroxisome proliferator - activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH
por: Long, Mary J, et al.
Publicado: (2009)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Correlation of Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) and Retinoid X Receptor-α (RXR-α) expression with clinical risk factors in patients with advanced carotid atherosclerosis
por: Giaginis, Constantinos, et al.
Publicado: (2011)

Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors
por: Palamaris, Kostas, et al.
Publicado: (2023)

Osteoarthritis: Role of Peroxisome Proliferator-Activated Receptors
por: Sheng, Weibei, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

The role of vitamin D in polycystic ovary syndrome
por: Lin, Ming-Wei, et al.
Publicado: (2015)

Role of Statin Drugs for Polycystic Ovary Syndrome
por: Cassidy-Vu, Lisa, et al.
Publicado: (2016)

Role of Peroxisome Proliferator-Activated Receptors in Inflammation Control
por: Youssef, Jihan, et al.
Publicado: (2004)

The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer
por: Park, Joo-In, et al.
Publicado: (2012)

The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
por: Gao, Jianjun, et al.
Publicado: (2022)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c3ulmrdh43lgbl28himpveg1a0